EyePoint Pharmaceuticals, Inc. ( EYPT) - Stock Earnings
EYPT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
EYPT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -67.6 million USD | 620000 USD |
| 2026Q1 | -84.8 million USD | 696000 USD |
| 2026Q2 | -94.5 million USD | 507000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EYPT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -70.8 million USD | 46.0 million USD |
| 2024 | -130.9 million USD | 43.3 million USD |
| 2025 | -232.0 million USD | 31.4 million USD |
| 2026 Est. | — | — |
EYPT
Price: $2.99
52 week price:
Earnings Per Share: -3.75 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 166382
Market Capitalization: 272.5 million